IMV
IMV Inc. Common Shares
Delisted
IMV was delisted on the 28th of April, 2023.
About: IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
Employees: 63
Charts implemented using Lightweight Charts™